The evidence comes from cell and animal models
Current treatments are largely palliative and do not address the underlying fibrosis
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide made of 15 amino acids, derived from a fragment of a protective protein found in human gastric juice
(8) As both TB-500 and BPC-157 peptides appear to exhibit similar pharmacological potential, when blended together, the potential action of both may be maximized what would otherwise occur with one peptide, might occur at a better, faster rate when combined
Glucagon receptor activation increases energy expenditure and promotes fat oxidation in ways that differ from earlier obesity medications
If you are considering these treatments, consult with a medical professional experienced in hormone therapy to determine the optimal approach for your specific needs.